The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

January 2, 2016

Primary Completion Date

December 29, 2016

Study Completion Date

December 30, 2016

Conditions
Nutritional DisorderHypertensionMineral Deficiency
Interventions
DIETARY_SUPPLEMENT

group/arm C (control group)

Group C in the third stage (30 days) continued drug use with no change in diet and no mineral supplementation.

DIETARY_SUPPLEMENT

group/arm D (diet group)

Group D in the third stage (30 days) received an optimal-mineral-content properly balanced diet enriched in food with high zinc content.

DIETARY_SUPPLEMENT

group/arm S (supplementation group)

Group S in the third stage (30 days) received zinc supplementation as one capsule containing 15 mg of Zn taken orally once a day in the morning, two hours after antihypertensive drug administration with no change in diet.

Trial Locations (1)

60-624

Poznan University of Life Sciences, Poznan

All Listed Sponsors
collaborator

Poznan University of Medical Sciences

OTHER

lead

Poznan University of Life Sciences

OTHER

NCT03465462 - The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies | Biotech Hunter | Biotech Hunter